Jul 29 2013

Global Advocate for Neuroendocrine Cancer Patients Announces New Name — International Neuroendocrine Cancer Alliance (INCA)

The International Neuroendocrine Cancer Alliance (INCA) announced its new name, the official one to be used by the organization, which has committed to being the global advocate for neuroendocrine cancer patients. Envisioning a world where all neuroendocrine cancer patients get a timely diagnosis, the best care and ultimately a cure, INCA (formerly known as the Worldwide NET Cancer Awareness Day Alliance) was established in 2010 in Berlin, Germany. The key focus of the Alliance, whose current members are NET patient groups and advocacy organizations from Asia, Australia, Europe, and North America, is to raise awareness of neuroendocrine cancer in the healthcare community and throughout the general public.

“It is the passion to change things for the betterment of neuroendocrine cancer patients that drives us forward as a deeply committed team, to unite patient advocates from around the globe in this effort,” commented Grace Goldstein, President of INCA and Chief Operating Officer of the Carcinoid Cancer Foundation in New York, USA.

Encouraging early diagnosis by working collaboratively with the healthcare community and the public, the Alliance also recognizes universal access to high-quality multidisciplinary care and the dissemination of accurate and user-friendly information about neuroendocrine cancer as its top priorities.

INCA also serves as a global platform to support existing and new patient-focused neuroendocrine groups and advocacy organizations from around the world. By maximizing the resources of its current members and actively reaching out to new ones, INCA encourages sharing best practices and experience, which is crucial in the context of rare cancers.Netty Announces New Name of International Neuroendocrine Cancer Alliance (INCA)